Vijaya Diagnostic Centre Ltd.
Snapshot View

422.40 +2.40 ▲0.6%

02 February 2023, 04:01:00 PM
Volume: 5,437

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Hospital & Healthcare Services Compare with Industry peers
Website http://www.vijayadiagnostic.com
Market Cap 4,311.41 Cr.
Enterprise Value(EV) 4,146.68 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 8.80 Trailing Twelve Months Ending 2022-09
Price-Earning Ratio (PE) 48.03 Trailing Twelve Months Ending 2022-09
Industry PE 46.37 Trailing Twelve Months Ending 2022-09
Book Value / Share 49.03 Trailing Twelve Months Ending 2022-09
Price to Book Value 8.62 Calculated using Price: 422.40
Dividend Yield 0.24 Period Ending 2022-03
No. of Shares Subscribed 10.21 Cr. 102,069,262 Shares
FaceValue 1
Company Profile
The company is one of the fastest-growing diagnostic chains in Southern India. It offers a one-stop solution for pathology and radiology testing services.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+0.57%
1 Week
+2.82%
1 Month
-1.25%
3 Month
-10.77%
6 Month
+14.13%
1 Year
-17.81%
2 Year
5 Year
10 Year
4 years 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 22.58 26.07 26.91 26.85
Return on Capital Employed (%) 31.56 35.47 37.97 39.37
Return on Assets (%) 11.42 14.11 16.76 17.85

Balance Sheet View Details >>

Particulars 5 years 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 207 275 359 468 500
Non Curr. Liab. 141 148 132 169 215
Curr. Liab. 57 59 44 66 73
Minority Int. 0 0 0 1 2
Equity & Liab. 405 481 535 705 791
Non Curr. Assets 268 294 296 435 519
Curr. Assets 137 186 239 270 272
Misc. Exp. not W/O
Total Assets 405 481 535 705 791

Profit Loss View Details >>

Particulars 5 years 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09 Rs. Cr. TTM
Net Sales 293 339 377 462 452
Other Income 10 15 12 13 12
Total Income 303 354 389 475 465
Total Expenditure -184 -206 -211 -259 -268
PBIDT 118 148 178 217 197
Interest -14 -15 -15 -16 -18
Depreciation -40 -49 -50 -53 -58
Taxation -19 -21 -27 -37 -30
Exceptional Items
PAT 46 63 85 111 90
Minority Interest -1 -1 -1
Share Associate
Other Related Items
Consolidated Net Profit 46 63 84 110 90
Adjusted EPS 102 138 8 11 9

Cash Flow View Details >>

Particulars 4 years 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 91 106 130 158
Cash Fr. Inv. -90 -31 -130 -123
Cash Fr. Finan. -7 -30 -49 -31
Net Change -7 46 -49 4
Cash & Cash Eqvt 10 56 7 11

Shareholding Pattern View Details >>

6 Qtrs 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 54.78 54.78 54.78 55.04 55.01 55.01
Public 45.22 45.22 45.22 44.96 44.99 44.99
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Thu, 02 Feb 2023
Board Meeting Intimation for Approval Of Unaudited Financial Results (Standalone & Consolidated) For The Quarter And Nine Months Ended 31/12/2022
Vijaya Diagnostic Centre Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2023 inter alia to consider and approve 1. The Unaudited Financial Results (both Standalone and Consolidated) for the third quarter and nine months ended 31st December 2022; and2. Other Corporate Matters.
Mon, 09 Jan 2023
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
We hereby certify that the details of securities dematerialized/rematerialized during the quarter ended December 31 2022 as required under Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 have been furnished to all the stock exchanges where the shares of the Company are listed. The letter confirming the same from our RTA - KFin Technologies Limited dated January 04 2023 is enclosed for your reference. Further the securities comprised in the said certificate if any have been listed on the Stock Exchanges where earlier issued securities of the Company were listed.
Mon, 09 Jan 2023
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby give the following details of the proposed schedule of Analyst / Institutional Investor meeting with the Company:Date of Meeting: January 10 2023Event: Group Meeting with AnalystsType of the Meeting: Physical MeetingVenue of the Meeting: Registered Office Hyderabad.

Technical Scans View Details >>

Thu, 02 Feb 2023
Close Crossing Last Week High Close Crossing Last Week High
Opening at Low Opening at Low
Making Higher Highs for 3 days Making Higher Highs for 3 days
Close Above Last Week High Close Above Last Week High
High Decrease in 3 Months High Decrease in 3 Months

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 241,852.96 1,008.00 -0.6%
Divi's Laboratories Ltd. 86,732.57 3,271.90 -2.5%
Cipla Ltd. 82,728.22 1,024.95 -0.7%
Dr. Reddy's Laboratories Ltd. 72,771.66 4,366.00 +0.4%
Apollo Hospitals Enterprise Ltd. 60,864.05 4,234.95 -0.8%
Torrent Pharmaceuticals Ltd. 52,144.29 1,541.15 +0.5%
Zydus Lifesciences Ltd. 43,787.95 432.60 -0.7%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 57.42 1,008.00 -0.6%
Divi's Laboratories Ltd. Consolidated 2022-09 29.03 3,271.90 -2.5%
Cipla Ltd. Consolidated 2022-12 31.36 1,024.95 -0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 19.95 4,366.00 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 72.52 4,234.95 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 62.77 1,541.15 +0.5%
Zydus Lifesciences Ltd. Consolidated 2022-09 22.59 432.60 -0.7%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.37 1,008.00 -0.6%
Divi's Laboratories Ltd. Consolidated 2022-09 7.16 3,271.90 -2.5%
Cipla Ltd. Consolidated 2022-12 3.65 1,024.95 -0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.30 4,366.00 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 10.17 4,234.95 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.18 1,541.15 +0.5%
Zydus Lifesciences Ltd. Consolidated 2022-09 2.63 432.60 -0.7%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 1,008.00 -0.6%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,271.90 -2.5%
Cipla Ltd. Consolidated 2022-03 0.04 1,024.95 -0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,366.00 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,234.95 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,541.15 +0.5%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 432.60 -0.7%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,008.00 -0.6%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,271.90 -2.5%
Cipla Ltd. Consolidated 2022-03 13.10 1,024.95 -0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,366.00 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,234.95 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,541.15 +0.5%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 432.60 -0.7%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,008.00 -0.6%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,271.90 -2.5%
Cipla Ltd. Consolidated 2022-03 13.10 1,024.95 -0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,366.00 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,234.95 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,541.15 +0.5%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 432.60 -0.7%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,008.00 -0.6%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,271.90 -2.5%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,024.95 -0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,366.00 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,234.95 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,541.15 +0.5%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 432.60 -0.7%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,008.00 -0.6%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,271.90 -2.5%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,024.95 -0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,366.00 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,234.95 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,541.15 +0.5%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 432.60 -0.7%

FAQ's On Vijaya Diagnostic Centre Ltd.

What is Vijaya Diagnostic share price?

Can I buy Vijaya Diagnostic shares now?

What is the Dividend Yield of Vijaya Diagnostic?

What is the Market Cap of Vijaya Diagnostic?

What are the key metrics to analyse Vijaya Diagnostic?

What is the 52 Week High and Low of Vijaya Diagnostic?

What is the trend of Vijaya Diagnostic share price?